المؤلفون: Elizabeth A M Feijen, Anna Font-Gonzalez, Elvira C van Dalen, Helena J H van der Pal, Raoul C Reulen, David L Winter, Claudia E Kuehni, Riccardo Haupt, Daniela Alessi, Julianne Byrne, Edit Bardi, Zsuzsanna Jakab, Desiree Grabow, Stanislaw Garwicz, Momcilo Jankovic, Gill A Levitt, Roderick Skinner, Lorna Zadravec Zaletel, Lars Hjorth, Wim J E Tissing, Florent de Vathaire, Mike M Hawkins, Leontien C M Kremer, PanCareSurFup consortium

المصدر: PLoS ONE, Vol 11, Iss 9, p e0162778 (2016)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: http://europepmc.org/articles/PMC5028033?pdf=render; https://doaj.org/toc/1932-6203

URL الوصول: https://doaj.org/article/fa5db5f61c8546108a9cde66a365cef3

المؤلفون: Yuehan Wang, Raoul C. Reulen, Leontien C.M. Kremer, Florent de Vathaire, Riccardo Haupt, Lorna Zadravec Zaletel, Francesca Bagnasco, Charlotte Demoor-Goldschmidt, Willem J. van Dorp, Nadia Haddy, Lars Hjorth, Zsuzsanna Jakab, Claudia E. Kuehni, Päivi M. Lähteenmäki, Helena J.H. van der Pal, Carlotta Sacerdote, Roderick Skinner, Monica Terenziani, Finn Wesenberg, Jeanette F. Winther, Flora E. van Leeuwen, Mike M. Hawkins, Jop C. Teepen, Elvira C. van Dalen, Cécile M. Ronckers

المساهمون: Paediatric Oncology, CCA - Cancer Treatment and Quality of Life, ARD - Amsterdam Reproduction and Development

المصدر: Wang, Y, Reulen, R C, Kremer, L C M, de Vathaire, F, Haupt, R, Zadravec Zaletel, L, Bagnasco, F, Demoor-Goldschmidt, C, van Dorp, W J, Haddy, N, Hjorth, L, Jakab, Z, Kuehni, C E, Lähteenmäki, P M, van der Pal, H J H, Sacerdote, C, Skinner, R, Terenziani, M, Wesenberg, F, Winther, J F, van Leeuwen, F E, Hawkins, M M, Teepen, J C, van Dalen, E C & Ronckers, C M 2022, ' Male breast cancer after childhood cancer : Systematic review and analyses in the PanCareSurFup cohort ', European Journal of Cancer, vol. 165, pp. 27-47 . https://doi.org/10.1016/j.ejca.2022.01.001
European Journal of Cancer, 165, 27-47. Elsevier Limited

مصطلحات موضوعية: Adult, Male, Cancer Research, Data analyses, Incidence, Late effects, Breast Neoplasms, Male, Childhood cancer survivors, Male breast cancer, Cohort Studies, Oncology, Cancer Survivors, Risk Factors, Second cancer, Neoplasms, Systematic review, Humans, Female, Registries, 610 Medicine & health, Child, Cohort study, 360 Social problems & social services

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cace675b2128ac7c5ca0ec3030c03e1
https://doi.org/10.1016/j.ejca.2022.01.001

المؤلفون: Raoul C, Reulen, Maurice P, Zeegers, W Hamish B, Wallace, Clare, Frobisher, Aliki J, Taylor, Emma R, Lancashire, Dave L, Winter, Mike M, Hawkins, Hamish, Wallace

المساهمون: Complexe Genetica, Populatie Genetica, RS: NUTRIM - R4 - Gene-environment interaction

المصدر: Cancer Epidemiology Biomarkers & Prevention, 18(8), 2239-47. American Association for Cancer Research Inc.

مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Epidemiology, Population, Childhood Cancer Survivor Study, Article, Miscarriage, Pregnancy, Neoplasms, Surveys and Questionnaires, medicine, Humans, Survivors, education, education.field_of_study, Radiotherapy, business.industry, Infant, Newborn, Pregnancy Outcome, Odds ratio, Infant, Low Birth Weight, medicine.disease, Abortion, Spontaneous, Low birth weight, England, Oncology, Premature birth, Premature Birth, Female, medicine.symptom, business, Live birth

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f4e9f537c18c0796736f9d94dc378f
https://doi.org/10.1158/1055-9965.EPI-09-0287

المؤلفون: Raoul C, Reulen, Aliki J, Taylor, David L, Winter, Charles A, Stiller, Clare, Frobisher, Emma R, Lancashire, Fabienne M, McClanahan, Elaine M, Sugden, Mike M, Hawkins, Hamish, Wallace

المصدر: International Journal of Cancer. 123:2156-2163

مصطلحات موضوعية: Adult, Risk, Cancer Research, medicine.medical_specialty, Population, Breast Neoplasms, Cohort Studies, Breast cancer, medicine, Humans, Cumulative incidence, Survivors, Risk factor, Child, education, Aged, education.field_of_study, business.industry, Incidence, Incidence (epidemiology), Cancer, Neoplasms, Second Primary, Middle Aged, medicine.disease, Surgery, Oncology, Relative risk, Multivariate Analysis, Female, Breast disease, business, SEER Program, Demography

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4e19aa5e93e7fdf68b7869ee243631
https://doi.org/10.1002/ijc.23743

المؤلفون: Streefkerk N; Department Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Jóźwiak K; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., De Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, The Netherlands., Van der Heiden-van Der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hollema N; Department of Anesthesiology, Intensive Care and Pain Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands., van den Berg M; Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Loonen J; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Versluys AB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology/Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Neggers SJCMM; Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., Hawkins M; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Hauptmann M; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Yoneoka D; Division of Biostatistics and Bioinformatics, Graduate School of Public Health, St. Luke's International University, Tokyo, Japan., Korevaar JC; Netherlands Institute for Health Services Research, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, University of Groningen/University Medical Center Groningen, Groningen, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

مؤلفون مشاركون: DCCSS LATER Study Group

المصدر: Cancer [Cancer] 2024 Apr 15; Vol. 130 (8), pp. 1349-1358. Date of Electronic Publication: 2023 Dec 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Survivors* , Neoplasms*/epidemiology , Neoplasms*/therapy , Neoplasms*/pathology, Child ; Humans ; Self Report ; Survivorship ; Survivors

المؤلفون: Hawkins M; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TY, UK m.m.hawkins@bham.ac.uk., Brownsdon A; University College London Hospitals NHS Foundation Trust, London, UK., Reulen R; Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TY, UK.

المصدر: BMJ (Clinical research ed.) [BMJ] 2020 Jan 15; Vol. 368, pp. m58. Date of Electronic Publication: 2020 Jan 15.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE

مواضيع طبية MeSH: Heart Diseases* , Neoplasms*, Accidental Falls ; Adult ; Child ; Cohort Studies ; Humans ; Survivors

المؤلفون: Stark D; Department of Cancer Medicine, Leeds, UK.; UK NCRI clinical studies group in Teenagers and Young Adults with cancer and Germ Cell Tumours, London, UK., Fern LA; National Cancer Research Institute Teenage, Young Adult and Germ Cell Clinical Studies Group, Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK., Gibson F; Child Health and Cancer Care, Great Ormond Street Hospital for Children NHS Foundation Trust and University of Surrey, London, UK., Hawkins M; Centre for Childhood Cancer Survivor Studies, University of Birmingham, Birmingham, UK., Hough R; Haematology and Haemopoietic Stem Cell Transplantation, UCL, London, UK.; University College London Hospital's NHS Foundation Trust, London, UK.; NHS England Clinical Reference Group for Children and Young People with Cancer, London, UK., McCabe MG; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Taylor R; Cancer Clinical Trials Unit, CNMR, University College London Hospitals NHS Foundation Trust, London, UK.

المصدر: European journal of cancer care [Eur J Cancer Care (Engl)] 2018 Nov; Vol. 27 (6), pp. e12962.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9301979 Publication Model: Print Cited Medium: Internet ISSN: 1365-2354 (Electronic) Linking ISSN: 09615423 NLM ISO Abbreviation: Eur J Cancer Care (Engl)

مواضيع طبية MeSH: Neoplasms/*therapy, Adolescent ; Humans ; Interprofessional Relations ; Patient Transfer/organization & administration ; Research ; Research Design ; Research Personnel ; Young Adult

المؤلفون: Haddy N; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.). nadia.haddy@gustaveroussy.fr., Diallo S; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., El-Fayech C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Schwartz B; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Pein F; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Hawkins M; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Veres C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Oberlin O; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Guibout C; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Pacquement H; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Munzer M; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., N'Guyen TD; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Bondiau PY; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Berchery D; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Laprie A; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Scarabin PY; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Jouven X; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Bridier A; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Koscielny S; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Deutsch E; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., Diallo I; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.)., de Vathaire F; From Radiation Epidemiology Group, INSERM, UMR1018, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., S.K., I.D., F.d.V.); Gustave Roussy, Villejuif, France (N.H., C.E.-F., B.S., C.V., O.O., C.G., A.B., S.K., E.D., I.D., F.d.V.); Université Paris XI, Villejuif, France (N.H., C.E.-F., B.S., C.V., C.G., I.D., F.d.V.); Centre Hospitalier de Gonesse, Service Pharmacie, Gonesse, France (S.D.); Institut de Cancérologie de l'Ouest, site René Gauducheau CLCC Nantes-Atlantique, Département de Recherche, Saint-Herblain, France (F.P.); Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology, University of Birmingham, United Kingdom (M.H.); Institut Curie, Paris, France (H.P.); CHU de Reims, Reims, France (M.M.); Institut Jean Godinot, Reims, France (T.D.N'G.); Centre Antoine Lacassagne, Nice, France (P.-Y.B.); Centre Claudius Régaud, Toulouse, France (D.B., A.L.); UMR 1018, University of Paris XI, Villejuif, France (P.-Y.S.); and INSERM U 970, Paris, France (X.J.).

المصدر: Circulation [Circulation] 2016 Jan 05; Vol. 133 (1), pp. 31-8. Date of Electronic Publication: 2015 Oct 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Heart Diseases/*etiology , Neoplasms/*drug therapy , Neoplasms/*radiotherapy, Adult ; Anthracyclines/adverse effects ; Antineoplastic Protocols ; Child ; Child, Preschool ; Cohort Studies ; Dose-Response Relationship, Drug ; Dose-Response Relationship, Radiation ; Female ; Heart Diseases/chemically induced ; Heart Diseases/epidemiology ; Humans ; Male ; Neoplasms/epidemiology ; Risk Factors

المؤلفون: de Vathaire F; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Haddy N; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Allodji RS; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Hawkins M; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Guibout C; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., El-Fayech C; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Teinturier C; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Oberlin O; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Pacquement H; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Diop F; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Kalhouche A; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Benadjaoud M; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Winter D; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Jackson A; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Bezin Mai-Quynh G; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Benabdennebi A; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Llanas D; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Veres C; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Munzer M; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Nguyen TD; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Bondiau PY; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Berchery D; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Laprie A; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Deutsch E; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Lefkopoulos D; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Schlumberger M; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Diallo I; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France., Rubino C; Radiation Epidemiology Group (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., I.D., C.R.), INSERM U1018 Villejuif, F-94805, France; Institut Gustave Roussy (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., D.L., M.S., I.D., C.R.), Villejuif, F-94805, France; Université Paris-Sud (F.d.V., N.H., R.S.A., C.G., C.E.-F., C.T., O.O., F.D., A.K., M.B., A.J., G.B.M.-Q., A.B., D.L., C.V., E.D., M.S., I.D., C.R.), Villejuif, F-94800, France; Centre for Childhood Cancer Survivor Studies, Department of Public Health & Epidemiology (M.H., D.W.), University of Birmingham, Birmingham B15 2TT, United Kingdom; Institut Curie (H.P.), Paris F-75005 Paris, France; Institut Jean Godinot (M.M., T.D.N.), F-51092 Reims, France; Centre Antoine Lacassagne (P.-Y.B.), F-06100 Nice, France; and Centre Claudius Régaud (D.B., A.L.), F-51100 Toulouse, France.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2015 Nov; Vol. 100 (11), pp. 4282-90. Date of Electronic Publication: 2015 Sep 01.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Radiation-Induced/*epidemiology , Radiotherapy/*adverse effects , Thyroid Neoplasms/*epidemiology, Adolescent ; Antineoplastic Agents/adverse effects ; Child ; Child, Preschool ; Cohort Studies ; Dose-Response Relationship, Radiation ; Humans ; Incidence ; Infant ; Infant, Newborn ; Nitrosourea Compounds/adverse effects ; Obesity/complications ; Obesity/epidemiology ; Pituitary Gland/radiation effects ; Radiation Dosage ; Retrospective Studies ; Risk Factors ; Splenectomy ; Thyroid Gland/radiation effects

المؤلفون: de Vathaire F; Université Paris-Sud, Villejuif, France. Electronic address: florent.devathaire@gustaveroussy.fr., Scwhartz B; Université Paris-Sud, Villejuif, France., El-Fayech C; Université Paris-Sud, Villejuif, France., Allodji RS; Université Paris-Sud, Villejuif, France., Escudier B; Radiation Epidemiology Group, INSERM U1018, Institut Gustave Roussy, Villejuif, France., Hawkins M; Centre for Childhood Cancer Survivor Studies, Department of Public Health and Epidemiology, University of Birmingham, Birmingham, United Kingdom., Diallo I; Université Paris-Sud, Villejuif, France., Haddy N; Université Paris-Sud, Villejuif, France.

المصدر: The Journal of urology [J Urol] 2015 Nov; Vol. 194 (5), pp. 1390-5. Date of Electronic Publication: 2015 Jul 02.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Forecasting*, Antineoplastic Agents/*therapeutic use , Carcinoma, Renal Cell/*epidemiology , Kidney Neoplasms/*epidemiology , Neoplasms, Second Primary/*epidemiology , Risk Assessment/*methods, Adolescent ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/radiotherapy ; Child ; Child, Preschool ; Dose-Response Relationship, Radiation ; Female ; Follow-Up Studies ; France/epidemiology ; Humans ; Incidence ; Infant ; Infant, Newborn ; Kidney/drug effects ; Kidney/radiation effects ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/radiotherapy ; Male ; Neoplasms, Second Primary/therapy ; Radiotherapy, Adjuvant ; Retrospective Studies ; Risk Factors ; United Kingdom/epidemiology